Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB06212_nanopub.RAuXs3uoM8RsOLn5bhPplifSfOsQu7qbtpresCaXuMXRA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB06212 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB06212 label "DDI between Voriconazole and Tolvaptan - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of Tolvaptan by decreasing its metabolism. Concomitant therapy is contraindicated. [drugbank_resource:DB00582_DB06212]" assertion.
- drugbank_resource:DB00582_DB06212 identifier "drugbank_resource:DB00582_DB06212" assertion.
- drugbank_resource:DB00582_DB06212 title "DDI between Voriconazole and Tolvaptan - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of Tolvaptan by decreasing its metabolism. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB06212 assertion.
- drugbank:DB06212 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB06212 assertion.